CA12
genyn codio-protien yn y rhywogaeth Homo sapiens
Protein sy'n cael ei godio yn y corff dynol gan y genyn CA12 yw CA12 a elwir hefyd yn Carbonic anhydrase 12 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn ôl o gromosom dynol 15, band 15q22.2.[2]
CA12 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | |||||||||||||||||
| |||||||||||||||||
Dynodwyr | |||||||||||||||||
Cyfenwau | CA12, CAXII, HsT18816, CA-XII, T18816, carbonic anhydrase 12 | ||||||||||||||||
Dynodwyr allanol | OMIM: 603263 HomoloGene: 20327 GeneCards: CA12 | ||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
Orthologau | |||||||||||||||||
Species | Bod dynol | Llygoden | |||||||||||||||
Entrez |
| ||||||||||||||||
Ensembl |
| ||||||||||||||||
UniProt |
| ||||||||||||||||
RefSeq (mRNA) |
| ||||||||||||||||
RefSeq (protein) |
| ||||||||||||||||
Lleoliad (UCSC) | n/a | n/a | |||||||||||||||
PubMed search | [1] | n/a | |||||||||||||||
Wicidata | |||||||||||||||||
|
Cyfystyron
golyguYn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn CA12.
- CAXII
- CA-XII
- T18816
- HsT18816
Llyfryddiaeth
golygu- "Essential role of carbonic anhydrase XII in secretory gland fluid and HCO3 (-) secretion revealed by disease causing human mutation. ". J Physiol. 2015. PMID 26486891.
- "Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells. ". Oncotarget. 2015. PMID 25686827.
- "CAXII Is a sero-diagnostic marker for lung cancer. ". PLoS One. 2012. PMID 22439015.
- "Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis. ". Oral Oncol. 2012. PMID 22172588.
- "Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.". Pharmacogenet Genomics. 2011. PMID 21278619.